Vireo Growth (OTCMKTS:VREOD) vs. Journey Medical (NASDAQ:DERM) Critical ContrastDefense World · Oct 6, 2026
Journey Medical: A Small Pharma With A Large Growth OpportunitySeeking Alpha · Sep 19, 2026
Journey Medical Corporation to Participate in September 2026 Investor ConferencesGlobeNewsWire · Sep 8, 2026
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?Zacks Investment Research · Aug 25, 2026
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains TractionSeeking Alpha · Aug 19, 2026
Journey Medical Corporation (DERM) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 12, 2026Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 12, 2026 | -$0.02 | -$0.01 | Beat |
| May 13, 2026 | -$0.07 | -$0.08 | Miss |
| Mar 25, 2026 | -$0.06 | -$0.04 | Beat |
| Nov 12, 2025 | -$0.08 | -$0.09 | Miss |
| Aug 12, 2025 | -$0.07 | -$0.16 | Miss |
| May 14, 2025 | -$0.24 | -$0.18 | Beat |